PharmEasy plans to re-enter the IPO market following a major business overhaul. The company aims to discuss its IPO strategy, ...
Swiss biopharma company BioVersys said on Tuesday it plans to list on the Swiss stock exchange in the first quarter with an initial public offering that aims to raise around 80 million Swiss francs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback